Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanistic Study of Epithelial miRNAs in Asthma
NCT02230189Phase 2Completed
- Sponsor
- Prescott Woodruff
- Start
- Mar 2015
- Primary completion
- Jan 2020
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by Prescott Woodruff. Primary endpoint: Difference in Expression of Epithelial miRNAs (in Read Counts) at 24 hours. Started Mar 2015; status: completed.
Beyond the preview
Go deeper on NCT02230189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02230189.